Beyond Conventional Analgesics: Updated Evidence Supporting Botulinum Toxin Type A for-Neuralgia Management.

Int J Med Sci · 2026 · PMC13048893 · PMID 41938503

Europe PMC DOI

hedged sentence

0.0860

closest p · 1.7× alpha

0.0860

boldest claim

The sentences

did not reach statistical significancep = 0.086so close (0.05 < p ≤ 0.1)

In contrast, studies administering 76-100 U did not reach statistical significance (SMD = -0.804, 95% CI: -1.721 to 0.113, p = 0.086), and substantial heterogeneity was observed in this subgroup ( I2 = 77.125%, p = 0.037).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.